William Duke
Director of Finance/CFO bij INVIVYD, INC.
Vermogen: - $ op 31-03-2024
Actieve functies van William Duke
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INVIVYD, INC. | Comptroller/Controller/Auditor | 01-09-2023 | - |
| Director of Finance/CFO | 01-09-2023 | - |
Loopbaan van William Duke
Eerdere bekende functies van William Duke
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| APEXIGEN, INC. | Director of Finance/CFO | 10-06-2022 | 23-08-2023 |
| Investor Relations Contact | 10-06-2022 | 23-08-2023 | |
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 25-11-2019 | - |
| Director of Finance/CFO | 25-11-2019 | 08-04-2022 | |
| PULMATRIX, INC. | Director of Finance/CFO | 25-06-2015 | 22-11-2019 |
| Corporate Secretary | 25-06-2015 | 22-11-2019 | |
| Treasurer | 25-06-2015 | 22-11-2019 | |
| VALERITAS INC | Comptroller/Controller/Auditor | 01-07-2011 | - |
| Director of Finance/CFO | 01-07-2011 | 01-06-2015 | |
| Investor Relations Contact | 01-07-2011 | 01-06-2015 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01-01-2010 | - |
| HAEMONETICS CORPORATION | Comptroller/Controller/Auditor | 01-05-2008 | 01-01-2010 |
| Director of Finance/CFO | 01-05-2008 | 01-01-2010 | |
| g8wave Holdings, Inc. | Director of Finance/CFO | 27-08-2007 | 16-05-2008 |
OTF Group, Inc.
 OTF Group, Inc. Miscellaneous Commercial ServicesCommercial Services OTF Group, Inc. provided management consulting services. The company was founded in 2000 and was headquartered in Belmont, MA. | Director of Finance/CFO | - | - |
Opleiding van William Duke
| Bentley University | Masters Business Admin |
| Stonehill College, Inc. | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 12 |
Operationeel
| Director of Finance/CFO | 9 |
| Comptroller/Controller/Auditor | 4 |
| Investor Relations Contact | 2 |
Sectoraal
| Health Technology | 8 |
| Consumer Services | 3 |
| Communications | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| PULMATRIX, INC. | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| g8wave Holdings, Inc. | Communications |
OTF Group, Inc.
OTF Group, Inc. Miscellaneous Commercial ServicesCommercial Services OTF Group, Inc. provided management consulting services. The company was founded in 2000 and was headquartered in Belmont, MA. | Commercial Services |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
- Beurs
- Insiders
- William Duke
- Ervaring
